Emerging Biotech weekly

July​ 26,​ 2022 | This week's startup news for biopharma leaders

Note from the editor


New medicines don’t appear out of thin air. Each are stories of people and perseverance. The big idea someone believed in and risked failure to pursue. The investors convinced it might work. And the startup companies that spend years, or even decades, trying to turn an idea into a drug that changes lives.

These stories drive the biotechnology industry and the sprawling research ecosystem that supports it. They will be the focus of this newsletter, which will run weekly on Tuesday mornings.

We’ll give you a unique look into the world of biotech startups, the people who back them and the challenges they face. You can expect a regular mix of insight, analysis, data and story formats that you won’t find anywhere else. Sound like something a colleague would enjoy? You can refer them using this link: https://www.biopharmadive.com/signup/emerging-biotech/?signup_referred_by=

We’ll have more to share in the weeks ahead. In the meantime, please send us any feedback, questions or tips. Thanks for reading BioPharma Dive!

Ben Fidler
Senior Editor, BioPharma Dive







Read more news

What We're Reading




Suggest a story we should read

Upcoming Events

Webinar | 2:00PM ET
Decentralization: The Evolution of Clinical Trial Design
Presented by studioID and MRN

Webinar | 2:00PM ET
Build An Effective Drug Discount Management Program for Your Organization
Presented by Kalderos

Webinar | 2:00PM ET
Addressing Personalized Medicine’s Complexity Problem: Examples from Parkinson’s Disease
Presented by studioID and Rho

Dive Into a Topic



Share BioPharma Dive: Emerging Biotech Weekly with others and get rewarded.


You've referred 0 readers.


To become an official Dive Insider, just successfully refer 10 contacts to BioPharma Dive: Emerging Biotech Weekly. Here's your link to share: https://www.biopharmadive.com/signup/insiders/?signup_referred_by=